Section 37-27-302 - Administration of prescription drugs - when prohibited - when allowed - protocols - rulemaking(1) Except as provided in subsections (2) and (3), a licensed direct-entry midwife may not dispense or administer prescription drugs.(2) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology and intravenous therapy approved by the board and has obtained a license endorsement from the board may, during the practice of midwifery, directly obtain and administer the following: (b) postpartum antihemorrhagic agents, including: (i) pitocin (intramuscular);(iv) tranexamic acid; and(v) other postpartum antihemorrhagic drugs allowed by board rule;(c) injectable local anesthetics for the repair of up to second-degree lacerations;(d) antibiotics for group b streptococcus prophylaxis consistent with guidelines of the United States centers for disease control and prevention;(e) epinephrine administered for anaphylactic shock;(f) intravenous fluids for fluid replacement and administration of approved medications;(g) rho(d) immune globulin to prevent maternal immune sensitization to certain fetal blood types;(h) newborn vitamin K or phytonadione (oral or intramuscular preparations);(i) in accordance with administrative rules adopted by the department of public health and human services, prophylactic eye agents to newborn infants; and(j) other medications as prescribed by a medical practitioner or naturopathic physician, including the use of devices as defined in 37-2-101.(3) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology pursuant to subsection (2) may, during the practice of midwifery: (a) directly obtain terbutaline; and(b) administer terbutaline to a patient when given a direct order to do so from a licensed physician.(4) A licensed direct-entry midwife who administers drugs under this section must establish written protocol, including but not limited to: (a) procurement of prescription drugs, which must be procured from a wholesale drug distributor or pharmacy supplier licensed by the board of pharmacy provided for in 2-15-1733;(b) storage, inventory control, and disposal of prescription drugs; and(c) use and care of prescription drugs.(5) The board may adopt rules to implement this section.Amended by Laws 2023, Ch. 262,Sec. 1, eff. 10/1/2023.En. Sec. 11, Ch. 550, L. 1991; amd. Sec. 42, Ch. 44, L. 2007.